Sarepta Therapeutics, Inc. (SRPT)

81.22
NASDAQ
Prev Close 84.19
Day Low/High 79.88 / 84.81
52 Wk Low/High 65.30 / 181.83
Exchange NASDAQ
Shares Outstanding 86.02B
Market Cap 7.24B
P/E Ratio N/A
Div & Yield N.A. (N.A)
Brace for a New High

Brace for a New High

End-of-month window-dressing could be the catalyst.

Building a Foundation

Building a Foundation

We remain in an uptrend and have not breached any key technical levels.

The Slow, Steady Climb Continues

The Slow, Steady Climb Continues

Being anticipatory or overly reactive is a good way to find yourself out of position.

Sarepta rated new Buy at Deutsche

Another Day, Another Gain

Another Day, Another Gain

One of the oddest market runs I can remember.

Catching Our Breath

Catching Our Breath

The action is a bit choppy as market players figure out there's time for a little rest before running more.

Beyond the Dow Euphoria

Beyond the Dow Euphoria

These trades may not be playable today, but they are setting up for the near future.

Phony Dow Mania Bites the Dust

Phony Dow Mania Bites the Dust

With this emotional level out of the way, maybe logic can apply again.

The Beat Goes On

The Beat Goes On

The slow, steady push higher continues.

The Next Big Thing In Biotech: 2013 Outlook

The Next Big Thing In Biotech: 2013 Outlook

Adam Feuerstein, Sr. Columnist for TheStreet, offers his outlook for the best and worst biotech stock in the coming year.

A Market for All Seasons

A Market for All Seasons

The market is in OK shape at this point.

Traders Looking for Action

Traders Looking for Action

It's a flipper's market, and some small-caps and mortgage plays are on the move.

'Junk Stock' Trading Time

'Junk Stock' Trading Time

Move fast and maintain a very high level of discipline.

Off the Charts

Off the Charts

The market still has a lot to prove but every rally needs to start somewhere.

It's Just a Bounce

The easiest mistake to make is to be too bullish too fast.

Downright Dull

The market is always more entertaining when strong emotions are at work.

The Next Big Thing in Biotech

The Next Big Thing in Biotech

Adam Feuerstein, senior columnist for TheStreet, says biotech earnings are the next big thing to watch in biotech.

Momentum Is Missing

Momentum Is Missing

Despite the softer open, buyers just don't appear to be motivated.

The Gap-Up Invites Selling

The Gap-Up Invites Selling

We're seeing mostly fades, though all major sectors are still up.

The S&P Forms a Bearish Setup

The S&P Forms a Bearish Setup

It's wedging toward resistance and could be preparing to pull back.

A Few Bright Spots

I don't like the overall market action, so I'm focusing on these individual stocks today.

Keeping Cautious

Keeping Cautious

I have not been impressed by the price action lately.

Morning Es Trading

Morning Es Trading

Traders will likely take their early cue from the premarket ADP data.

Positive ISM Report Puts Bears on the Run

Positive ISM Report Puts Bears on the Run

Traders who were ready to fade the open are now scrambling for position.

Looks Toppy Out There

Looks Toppy Out There

The bears will be pressing if the S&P 500 takes out the recent low.

The Bulls Lack Energy

The Bulls Lack Energy

The market gapped up to open but it is slowly fading.

Dip-Buyers Go Into Hiding

Dip-Buyers Go Into Hiding

Make the necessary defensive moves and take those stops, even if it's painful.

Another Weak Monday

Another Weak Monday

A sloppy morning of selling so far.

A Minor Hiccup

A Minor Hiccup

No major support has been breached today and the trend is still to the upside.